Delivery Order SPE2DB20D3104-SPE2DB23FV5Z7

Award Date 4/10/23
Potential Completion Date 4/11/23
Potential Value $7.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,791.11, is for the delivery of Descovy 200-25 mg tablets. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00,...
This federal contract award, valued at $17,203.55, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award covers the delivery of Descovy 200-25 mg Tablet, a prescription pharmaceutical product, to support defense and federal healthcare programs. The contract is a Firm Fixed Price Delivery Order, with a completion date of January 14, 2025. The award is not designated under any set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Descovy 200-25 mg tablets. The $9,615.52 firm-fixed-price contract has a completion date of March 2, 2023. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,962.31, is for the delivery of Descovy 200-25 mg tablets. The contract is a delivery order with a firm fixed price and has an ultimate completion date of April 25, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $9,667.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Descovy 200-25 mg tablets, a pharmaceutical product, and has a completion date of June 10, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, issued by the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $36,023.76 firm fixed-price delivery order is for the pharmaceutical product Descovy 200-25 mg Tablet, with a performance period through May 7, 2024. The award was made through full and open competition, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of Descovy 200-25 mg tablets to the Defense Logistics Agency (DLA). The $10,207.13 firm fixed-price delivery order, awarded to AmerisourceBergen Drug Corp, does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, is a subsidiary of the parent company Cencora, Inc. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA...
This federal contract award, valued at $36,307.91, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Descovy 200-25 mg tablet, a prescription medication, to support federal healthcare programs. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,049.26 firm-fixed-price delivery order covers the procurement of Descovy 200-25 mg tablets to support military treatment facilities and other federal healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc.,...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The award, valued at $16,706.70, is for the provision of Descovy 200-25 mg Tablet, a pharmaceutical product, to support military treatment programs and facilities. The contract has a firm fixed price pricing type and a period of performance through April 2, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery...
  • SPE2DB20D3104
    Indefinite Delivery Contract
  • SPE2DB20D3104-SPE2DB23FV5Z7
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,129.34, is a delivery order for the drug product Descovy 200-25 mg tablet. The contract has a firm fixed price pricing type and an ultimate completion date of April 11, 2023. This award is not associated with any set-aside designation, indicating open competition.

AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has extensive experience providing pharmaceutical products and medical supplies to various government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999, that serves as the primary vehicle for delivering a comprehensive range of pharmaceutical and medical commodities to support military healthcare programs globally.

Generated 5/9/25, 9:45 AM